CATENA ADVISORY
Support for healthcare technology teams across product, evidence, adoption and growth.
Email StewartOur Six-Link FrameworkChoose a focused project or ongoing advice. We agree the question, scope and deliverables before work starts.
Decide what to build and why it matters. We review your product, clarify its clinical purpose and identify the changes that deserve priority.
A clinical product brief, prioritised recommendations and questions to test with users.
See the approach and get the guide →Test how your product fits clinical work. We examine usability, handovers and workload, then plan a pilot around the questions that matter.
A workflow map, structured feedback and a pilot plan with meaningful measures. Formal study delivery is scoped separately.
Find a credible route to customers. We clarify who uses, champions and buys your product, then strengthen your positioning and adoption case.
A target-customer and buyer map, value proposition, priority routes to market and a practical next-step plan.
Look beyond the demonstration. We examine product claims and evidence, assess their relevance to your setting and identify gaps that could change your decision.
A sourced decision brief, evidence gaps and focused questions for the company or evaluation team.
Prepare for specialist review or a pilot. We clarify intended use, organise evidence and identify unresolved clinical risk and oversight questions.
A readiness gap map, organised evidence and actions to take to appointed specialists. Certification, legal opinions and formal safety or regulatory sign-off are outside this advisory scope.
Tell a stronger investment story. We connect clinical need, evidence and commercial opportunity, improve your deck and prepare you for difficult questions.
A clearer investment narrative, deck structure and content, plus a prioritised list of diligence questions to prepare for.
Bring senior clinical judgement into your team. An agreed remit can cover product direction, evidence, clinician engagement and customer or investor conversations.
A defined clinical leadership or advisory remit, agreed availability and decision responsibilities.
One product. One clinical use case. One target market. A focused review gives you clear priorities for product development, evidence and buyer conversations.
Discuss a sprintKnowledge Studio turns approved expertise into onboarding, software walkthroughs and training.
Explore the Knowledge StudioCATENA · HEALTHCARE AI & MEDTECH ADVISORY
Catena provides healthcare AI and medtech advisory led by Dr Stewart Southey. Engagements connect clinical usefulness with evidence, workflow and commercial decisions, with a particular focus on perioperative care.
Before deciding what to build or buy, establish whose problem matters and what a better result would look like. A technically capable product may still struggle if it solves a minor inconvenience, adds work for the wrong person or depends on a service that cannot act on its findings.
Catena helps teams examine those assumptions early and turn broad ambitions into questions they can investigate.
For founders and product teams developing a healthcare tool or deciding where it should go next.
We can work through the intended use, clinical workflow and decisions the product supports. We examine what the evidence currently justifies, where claims run ahead of it and what further evaluation would be useful. The outcome can be a clearer clinical proposition, a prioritised set of evidence questions and a practical brief for the next stage of development.
This work can also help a team prepare for conversations with clinicians, prospective customers and specialist regulatory advisers.
For healthcare teams considering a product or planning a pilot.
The starting point is your service: the patients, staff, existing process and the problem you want to improve. We can assess the fit of a proposed tool, examine how its evidence transfers to that setting and identify changes needed in staffing, integration and responsibility.
A useful evaluation should show what happens after an output appears. Proposed measures can include clinical decisions, workload, missed problems, patient experience and costs, rather than relying only on model accuracy or activity counts.
For investors and leadership teams assessing a healthcare technology opportunity.
Catena can provide a clinical perspective on the need, intended use, evidence and adoption story. The emphasis is on the questions that could change the decision: whether the product supports a consequential task, whether the evidence matches the claims and what stands between a successful demonstration and routine use.
The findings can be presented as a concise decision brief, with supporting sources, uncertainties and questions for the company.
For medtech teams that need continuing senior clinical input as the product and business develop.
Depending on the brief, this could involve clinical product definition, evidence priorities, clinician engagement and communication of the clinical proposition. Stewart brings experience from previous Chief Medical Officer roles alongside current clinical practice and technology venture development.
The remit, decision authority, availability and deliverables would be agreed before an engagement starts. An advisory appointment should be explicit about who owns clinical, operational and regulatory decisions.
When people need to understand a new product or way of working, Catena can also help structure onboarding and training through its Knowledge Studio. Educational content is developed from agreed source material and reviewed for the audience and task it needs to support.
An engagement starts with the decision you face and the information already available. We then agree the scope, access to relevant material and the form of the output. Work may be a focused review, a project or an ongoing advisory relationship.
Clinical and commercial advice should make the next decision clearer. It should also make uncertainty visible, including where further evidence or specialist advice is needed.
